BIOMAT Database Logo BIOMAT Database Logo

Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics. 1987

N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Charles A. Dana Marrow Transplant Unit, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000943 Antigens, Differentiation Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. Differentiation Antigen,Differentiation Antigens,Differentiation Antigens, Hairy Cell Leukemia,Differentiation Marker,Differentiation Markers,Leu Antigen,Leu Antigens,Marker Antigen,Marker Antigens,Markers, Differentiation,Antigen, Differentiation,Antigen, Leu,Antigen, Marker,Antigens, Leu,Antigens, Marker,Marker, Differentiation
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.
September 1988, Bone marrow transplantation,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes.
June 1987, Transplantation,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapy.
November 1990, Bone marrow transplantation,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.
November 1995, Blood,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning.
February 1987, Transplantation proceedings,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Suppressive activity in recipients of non-T cell-depleted allogeneic bone marrow transplants: role of T cell-depleted syngeneic marrow.
December 1989, Bone marrow transplantation,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.
September 1986, Blood,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Graft rejection after T-cell depleted marrow transplantation: role of fractionated irradiation.
April 1987, British journal of haematology,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia.
March 1996, Bone marrow transplantation,
N A Kernan, and C Bordignon, and C A Keever, and I Cunningham, and H Castro-Malaspina, and N H Collins, and T N Small, and J Brochstein, and D Emanuel, and J Laver
Irradiated donor buffy coat following T cell-depleted bone marrow transplants.
November 1988, Bone marrow transplantation,
Copied contents to your clipboard!